Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.

Gallery

Contacts

411 University St, Seattle, USA

[email protected]

+1 -800-456-478-23

Harnessing
Myeloid Biology

Our capabilities translate into unmatched product designs with transformative “full-immune” engagement.

// Next-Generation Immunotherapies

Our Pipeline

// About Myeloid

The Leaders in mRNA-based Immunotherapies

Our therapies incorporate advanced cell and gene therapy methods, combining immunology, genetics, cell biology, and protein science to improve the lives of patients in need.

Learn More

// OUR SCIENCE

Unlocking the Innate Abilities of Myeloid Cells

Our novel in vivo engineering platform targets and activates myeloid cells within solid tumors to elicit broader anti-tumor adaptive immunity — without the need for ex-vivo cell engineering.

LEARN MORE

In Vivo mRNA Programming

Our retrotransposon-mediated gene-insertion technology offers the potential to deliver larger genetic sequences into the genome than is currently possible with existing technologies.

LEARN MORE

CREATE Gene-Editing

Our mRNA technologies utilize myeloid cells to engulf cancer cells, produce anti-tumor agents, promote anti-tumor adaptive immunity, and alter the tumor microenvironment.

LEARN MORE